10 BÜCHER, DIE MIT «CYCLASE» IM ZUSAMMENHANG STEHEN
Entdecke den Gebrauch von
cyclase in der folgenden bibliographischen Auswahl. Bücher, die mit
cyclase im Zusammenhang stehen und kurze Auszüge derselben, um seinen Gebrauch in der Literatur kontextbezogen darzustellen.
This volume covers the evolution of the field, peptide hormone receptor work, membrane guanylate cycles, related retinal diseases, and the biochemistry and physiology of the soluble form. The 16 chapters are written by leaders in the field.
Rameshwar K. Sharma, 2002
2
Pituitary Adenylate
Cyclase-Activating Polypeptide
Pituitary Adenylate Cyclase-Activating Polypeptide is the first volume to be written on the neuropeptide PACAP.
Hubert Vaudry, Akira Arimura, 2002
3
Adenylyl
Cyclase, G Proteins, and Guanylyl
Cyclase
This volume emphasizes methods for the assay, purification, and characterization of adenylyl cyclases, guanine nucleotide-dependent regulatory proteins (G proteins), and guanylyl cyclases.
Roger A. Johnson, Jackie D. Corbin, 1991
4
Identification of Two Distinct Glutaminyl
Cyclase Isoforms ...
Localization studies demonstrated differential location of the two isoforms within the Drosophila melanogaster embryo.
Amanda Thigpen Parker, 2008
5
Vesicle Trafficking and Protein Synthesis, Target Adenylyl ...
Adenylyl cyclases and their product, 3'-5'-cyclic adenosine monophosphate (cAMP), are critical signaling molecules fundamental to many signaling pathways found throughout eukaryotes and mammals.
6
Nitric Oxide Signaling Through Soluble Guanylate
Cyclase
Soluble guanylyl/guanylate cyclase (sGC), the primary receptor for nitric oxide (NO), is a heme containing heterodimeric enzyme involved in numerous physiological events in animals.
7
Characterization of a Novel ADP-ribosyl
Cyclase Member in ...
Gel filtration revealed, in conjunction with photoaffinity labeling with 8N3-32P-NAD, that the non-CD38 cyclase was a low molecular weight protein, of approximately 21 kDa.
Angela Elizabeth Kell, 2006
8
Investigating the Heme Environment and Mechanism of ...
References (1) Kharitonov, V. G., Russwurm, M., Magde, D., Sharma, V. S., and
Koesling, D. (1997) Dissociation of nitric oxide from soluble guanylate cyclase.
Biochem. Bioph. Res. Co. 239, 284-286. (2) Kharitonov, V. G., Sharma, V. S., ...
Emily Rose Derbyshire, 2008
2.2. Effects. on. Adenylate. Cyclase. Even though the binding of cholera toxin to
cell membrane receptors is almost instantaneous, there is a substantial lag
period, 20-90 min, before this results in any detectable effects on cell metabolism.
Dhiman Barua, William B. Greenough, 1992
10
Structural Characterization of Guanylate
Cyclase Activating ...
Changes in the concentration of cyclic GMP link light detection to synaptic signaling.
10 NACHRICHTEN, IN DENEN DER BEGRIFF «CYCLASE» VORKOMMT
Erfahre, worüber man in den einheimischen und internationalen Medien spricht und wie der Begriff
cyclase im Kontext der folgenden Nachrichten gebraucht wird.
AstraZeneca and Ironwood Report Positive Top-Line Data from …
Linaclotide is a guanylate cyclase‐C (GC‐C) agonist that is thought to work in two ways based on nonclinical studies. Linaclotide binds to the ... «Business Wire, Jul 15»
Another Longevity Target
.This role of cAMP/PKA in aging may be conserved in mammals, as disruption of adenylyl cyclase 50 and PKA function extend murine lifespan ... «Corante, Jul 15»
Soluble Guanylate Cyclase (sGC) Activators – Pipeline Insights …
The Soluble Guanylate Cyclase (sGC) Activators Report helps to identify emerging players with potentially strong product information and ... «Medgadget.com, Jul 15»
Active Trending Stocks: Synergy Pharmaceuticals Inc (NASDAQ …
Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic ... «wsnewspublishers, Jul 15»
Canaccord Genuity Recommendation on Synergy Pharmaceuticals …
The Company's lead product candidate is plecanatide, a guanylyl cyclase C (GC-C), receptor agonist, to treat GI disorders, primarily chronic ... «Insider Trading Report, Jul 15»
Friday's Trade Stocks Highlights: Synergy Pharmaceuticals Inc …
Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic ... «wsnewspublishers, Jul 15»
Company Shares of Ironwood Pharmaceuticals, Inc. Rally 0.29%
The Company is engaged in the area of guanylate cyclase type-C (GC-C), agonists and in the science and treatment of gastrointestinal ... «OTC Outlook, Jul 15»
Today's Hot Stories - Advanced Micro Devices, (NASDAQ:AMD …
Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic ... «wsnewspublishers, Jul 15»
Protistology: How to build a microbial eye
In Blastocladiella emersonii, the type 1 rhodopsin photosensor contains a guanylyl cyclase domain, which allows the protein to control the ... «Nature.com, Jul 15»
Microplate Readers for HTRF Measurements
These receptors inhibit adenylyl cyclase. GalR2 also mediates calcium mobilization at the intracellular level. The galanin system, especially ... «News-Medical.net, Jul 15»
